|
TMEM123 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.02460287318718E-11 |
| Normal-vs-Stage2 |
8.84039996762453E-09 |
| Normal-vs-Stage3 |
8.27782287160517E-13 |
| Normal-vs-Stage4 |
1.6251444634463E-12 |
| Stage1-vs-Stage2 |
7.843800E-01 |
| Stage1-vs-Stage3 |
7.798000E-02 |
| Stage1-vs-Stage4 |
1.90904999999297E-05 |
| Stage2-vs-Stage3 |
3.566200E-01 |
| Stage2-vs-Stage4 |
1.297560E-02 |
| Stage3-vs-Stage4 |
2.347600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.75210973402318E-12 |
| Normal-vs-AfricanAmerican |
7.602100E-03 |
| Normal-vs-Asian |
1.40087941247202E-12 |
| Caucasian-vs-AfricanAmerican |
3.233000E-01 |
| Caucasian-vs-Asian |
2.560000E-01 |
| AfricanAmerican-vs-Asian |
1.691800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.69464442478784E-12 |
| Normal-vs-Female |
1.62414526272414E-12 |
| Male-vs-Female |
3.469000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.81410450497788E-11 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.01509911587527E-11 |
| Normal-vs-Age(81-100Yrs) |
1.309750E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.454800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.670000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.152600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.930800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.720800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.520200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.474010E-01 |
| Classical-VS-Follicular |
3.248200E-01 |
| Classical-VS-Other |
5.560800E-01 |
| Classical-VS-Normal |
1.84889881182926E-11 |
| Tall-VS-Follicular |
6.225700E-02 |
| Tall-VS-Other |
9.054600E-01 |
| Tall-VS-Normal |
5.72386582575746E-12 |
| Follicular-VS-Other |
4.393600E-01 |
| Follicular-VS-Normal |
9.59830004365614E-09 |
| Other-VS-Normal |
7.553500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.88578058618805E-15 |
| Normal-vs-N1 |
1.52433621281034E-13 |
| N0-vs-N1 |
5.570000E-02 |
|
|
